| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/03/2013 | US8524271 Skin wound dressing and preparing method thereof |
| 09/03/2013 | US8524263 Sheet-like cosmetic |
| 09/03/2013 | US8524260 Method for encapsulating oils in an aqueous medium with hase polymer emulsions, products obtained, and uses thereof |
| 09/03/2013 | US8524248 Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma |
| 09/03/2013 | US8524240 Diagnosis and therapy of hematological malignancies |
| 09/03/2013 | US8524216 Sterilizing polymer and method of preparation thereof |
| 09/03/2013 | US8524215 Absorbable PEG-based hydrogels |
| 09/03/2013 | US8524214 Polyal drug conjugates comprising variable rate-releasing linkers |
| 09/03/2013 | US8524213 Cohesive gel of hyaluronic acid or hylan crosslinked with divinyl sulfone characterized by percentage modification and ratio of crosslinks to pendant groups; use treating, osteoarthritis, preventing surgical adhesions, soft tissue augmentation, drug delivery systems |
| 09/03/2013 | US8524212 Prophylactic and/or therapeutic drug for nonalcoholic steatohepatitis |
| 09/03/2013 | US8524211 Vegetable sourced petrolatum cosmetic |
| 09/03/2013 | US8524210 Plant-derived elastin binding protein ligands and methods of using the same |
| 09/03/2013 | US8524199 Toothpaste composition |
| 09/03/2013 | US8523569 Controlled release local anesthetic for post dental surgery and method of use |
| 09/03/2013 | CA2806767A1 Patch and method for producing the same |
| 09/03/2013 | CA2747000C Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 09/03/2013 | CA2729292C Phenoxyphenyl sulfide, sulfinyl and sulfonyl antagonists of prostaglandin d2 receptors |
| 09/03/2013 | CA2707691C Sphingomyelin containing preparation |
| 09/03/2013 | CA2687172C Anti-norovirus agent and composition containing the same |
| 09/03/2013 | CA2667372C 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-one as cb1 receptor modulators |
| 09/03/2013 | CA2657090C Clear pharmaceutical aqueous microemulsion comprising propofol and process for preparation |
| 09/03/2013 | CA2630738C Immunostimulatory oligoribonucleotides |
| 09/03/2013 | CA2612292C Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
| 09/03/2013 | CA2612080C Immediate-release therapeutic systems for improved oral absorption of 7-[(e)-t-butyloxyiminomethyl] camptothecin |
| 09/03/2013 | CA2609441C 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |
| 09/03/2013 | CA2608814C Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases |
| 09/03/2013 | CA2603475C Acyl hydrazides as kinase inhibitors, in particular for sgk |
| 09/03/2013 | CA2603081C Device and methods for treating paranasal sinus conditions |
| 09/03/2013 | CA2602379C Method of increasing drug oral bioavailability and compositions of less toxic orotate salts |
| 09/03/2013 | CA2598993C Tetrahydroindolone and tetrahydroindazolone derivatives |
| 09/03/2013 | CA2596754C Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its uses for the treatment of inflammatory, autoimmune and proliferative diseases and disorders |
| 09/03/2013 | CA2595182C Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 09/03/2013 | CA2583373C Self-gelling alginate systems and uses thereof |
| 09/03/2013 | CA2573943C 6-formyltetrahydropteridines method for production and use thereof as medicament against cancer amongst other things |
| 09/03/2013 | CA2567704C Selective serotonin receptor inverse agonists as therapeutics for disease |
| 09/03/2013 | CA2561696C Novel modified galectin 9 proteins and use thereof |
| 09/03/2013 | CA2558211C Bicyclic and bridged nitrogen heterocycles |
| 09/03/2013 | CA2548662C Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 09/03/2013 | CA2548559C Intranasal compositions comprising granisetron and chitosan |
| 09/03/2013 | CA2522562C 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer |
| 09/03/2013 | CA2515262C Treatment of bacterial diseases of the respiratory organs |
| 09/03/2013 | CA2504963C Conjugates of tnf and a ligand of cd13 receptor in combination with interferon-gamma for treating cancer |
| 09/03/2013 | CA2489308C Use of taurine for the treatment of alopecia |
| 09/03/2013 | CA2464372C Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 09/03/2013 | CA2459807C Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 09/03/2013 | CA2428798C Fen-1 endonucleases from archaeoglobus veneficus |
| 09/03/2013 | CA2412581C Transforming growth factor beta (tgf-.beta.) blocking agent-treated stem cell composition and method |
| 09/03/2013 | CA2386810C Electrospun skin masks and uses thereof |
| 09/03/2013 | CA2333931C Polysaccharide vaccine for staphylococcal infections |
| 09/03/2013 | CA2241564C Wsx receptor and ligands |
| 08/29/2013 | WO2013126814A1 Compounds for inhibition of biofilms |
| 08/29/2013 | WO2013126805A2 Small molecule compounds to treat hearing loss |
| 08/29/2013 | WO2013126799A1 Compositions and methods for ocular delivery of a therapeutic agent |
| 08/29/2013 | WO2013126797A1 Cholecystokinin b receptor targeting for imaging and therapy |
| 08/29/2013 | WO2013126730A1 Derivatives of avicin d and methods of making and using thereof |
| 08/29/2013 | WO2013126697A1 Transdermal compositions and methods for treating stretch marks |
| 08/29/2013 | WO2013126694A1 Topical compositions comprising fipronil and permethrin and methods of use |
| 08/29/2013 | WO2013126669A1 Animal feed compositions and methods of using the same |
| 08/29/2013 | WO2013126664A1 Identification of nsc23925 isomers to reverse multidrug resistance in human cancers |
| 08/29/2013 | WO2013126656A1 Pyridopyrimidinone inhibitors of kinases |
| 08/29/2013 | WO2013126636A1 Methods for treating non- small cell lung cancer using tor kinase inhibitor combination therapy |
| 08/29/2013 | WO2013126617A1 Bouvardin derivatives and therapeutic uses thereof |
| 08/29/2013 | WO2013126608A1 Sulfonamide compounds and uses as tnap inhibitors |
| 08/29/2013 | WO2013126599A1 Meibomian gland dysfunction |
| 08/29/2013 | WO2013126595A1 Methods for treating corneal and conjunctival inflammation and inflammatory disorders |
| 08/29/2013 | WO2013126581A1 Methods and compositions related to glucocorticoid receptor antagonism and prostate cancer |
| 08/29/2013 | WO2013126552A1 Buprenorphine nanoparticle composition and methods thereof |
| 08/29/2013 | WO2013126550A2 New compositions, the preparation and use thereof |
| 08/29/2013 | WO2013126545A1 Methods and compositions for stimulating bone regeneration |
| 08/29/2013 | WO2013126539A1 Treatment of cancer |
| 08/29/2013 | WO2013126438A1 Sulfinylbenzyl and thiobenzyl derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 08/29/2013 | WO2013126428A1 Phenoxy derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 08/29/2013 | WO2013126381A1 Phenoxy-azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 08/29/2013 | WO2013126326A1 Solid forms of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, compositions and methods of use thereof |
| 08/29/2013 | WO2013126205A1 Mixed monoamine reuptake inhibitor in a biodegradable polymer carrier |
| 08/29/2013 | WO2013126156A1 Nitric oxide donating selective glucocorticoid receptor agonist compounds and ophthalmic compositions |
| 08/29/2013 | WO2013126149A1 Process to improve feed efficiency and carcass characteristics of animals |
| 08/29/2013 | WO2013126146A2 Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotate |
| 08/29/2013 | WO2013126132A1 Cyclic diaminopyrimidine derivatives |
| 08/29/2013 | WO2013126088A1 Methods of increasing light responsiveness in a subject with retinal degeneration |
| 08/29/2013 | WO2013125732A1 Aromatic ring compound |
| 08/29/2013 | WO2013124865A1 Drug delivery system for finasteride to prostate |
| 08/29/2013 | WO2013124860A1 Potent revital formulation |
| 08/29/2013 | WO2013124828A1 Substituted chroman compounds as calcium sensing receptor modulators |
| 08/29/2013 | WO2013124826A1 Oxazolidin- 2 -one compounds and uses thereof as pi3ks inhibitors |
| 08/29/2013 | WO2013124823A1 An improved process for the preparation of aprepitant |
| 08/29/2013 | WO2013124820A1 Composition comprising a retinoid and benzoyl peroxide |
| 08/29/2013 | WO2013124818A1 Taste masked dispersible tablets |
| 08/29/2013 | WO2013124791A1 Solid form of bosentan |
| 08/29/2013 | WO2013124774A1 Stable dosage forms of imatinib mesylate |
| 08/29/2013 | WO2013124768A1 Bilayer tablet of dronedarone |
| 08/29/2013 | WO2013124749A1 Novel polymorph of dabigatran etexilate |
| 08/29/2013 | WO2013124748A1 Novel polymorphs of azilsartan medoxomil potassium |
| 08/29/2013 | WO2013124484A1 Compositions and methods for the treatment of retinal degeneration |
| 08/29/2013 | WO2013124479A1 Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of reducing sebum production using same |
| 08/29/2013 | WO2013124441A1 Use of dialkyl-thiosulfinate and/or thiosulfonate to improve the resistance of an animal infected by a pathogen |
| 08/29/2013 | WO2013124416A1 Calcineurin inhibitors for use in the treatment of lesional vestibular disorders |
| 08/29/2013 | WO2013124413A1 Thiadiazolidinediones as gsk-3 inhibitors |
| 08/29/2013 | WO2013124403A1 Compounds for treating parvovirus infection |
| 08/29/2013 | WO2013124382A1 Peltatin for use in the treatment of cardiovascular disorders |